PAA 6.98% 23.0¢ pharmaust limited

Latest MND Webinar information on Monepantel, page-20

  1. 2,733 Posts.
    lightbulb Created with Sketch. 1497
    Id say you are not by yourself there. While the plan seems to be getting executed, I see very little skill or ability differences in driving value when compared with previous team.

    Yes it's all irrelevant if it works and this sells for billions, but that is not a given. We will be stuck holding an illiquid 4c share if the phase 2 doesn't hit it out of the park.

    The SP will recover but it seems perhaps we are back to where we were for the preceding 10 years relying on MPL and not the skill of management to drive value.
 
watchlist Created with Sketch. Add PAA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.